466 related articles for article (PubMed ID: 24746736)
1. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
[TBL] [Abstract][Full Text] [Related]
2. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
3. [Adherence to guidelines for the treatment of venous thromboembolism in cancer patients: a retrospective analysis of 145 cases].
Belhadj Chaidi R; Thollot C; Ferru A; Roblot P; Landron C
J Mal Vasc; 2013 May; 38(3):185-92. PubMed ID: 23619202
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S; Wendtner CM
Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
[No Abstract] [Full Text] [Related]
5. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
6. [Cancer and venous thromboembolism recurrence: The keys for an optimal management].
Mahé I; Benhamou Y; Helfer H; Chidiac J
Bull Cancer; 2018 May; 105(5):508-516. PubMed ID: 29544692
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
8. [Venous thromboembolism and cancer].
Meyer G
Rev Pneumol Clin; 2014; 70(1-2):91-4. PubMed ID: 24566034
[TBL] [Abstract][Full Text] [Related]
9. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.
Haas SK; Freund M; Heigener D; Heilmann L; Kemkes-Matthes B; von Tempelhoff GF; Melzer N; Kakkar AK;
Clin Appl Thromb Hemost; 2012; 18(2):159-65. PubMed ID: 22275397
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism prevention in patients undergoing colorectal surgery for cancer.
Holwell A; McKenzie JL; Holmes M; Woods R; Nandurkar H; Tam CS; Bazargan A
ANZ J Surg; 2014 Apr; 84(4):284-8. PubMed ID: 23782713
[TBL] [Abstract][Full Text] [Related]
13. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
14. Management of recurrent venous thromboembolism in cancer patients.
Romualdi E; Ageno W
Thromb Res; 2016 Apr; 140 Suppl 1():S128-31. PubMed ID: 27067966
[TBL] [Abstract][Full Text] [Related]
15. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.
Jameson SS; Baker PN; Charman SC; Deehan DJ; Reed MR; Gregg PJ; Van der Meulen JH
J Bone Joint Surg Br; 2012 Jul; 94(7):914-8. PubMed ID: 22733945
[TBL] [Abstract][Full Text] [Related]
16. Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?
Howlett J; Benzenine E; Fagnoni P; Quantin C
J Thromb Thrombolysis; 2020 Oct; 50(3):642-651. PubMed ID: 32020515
[TBL] [Abstract][Full Text] [Related]
17. Management of venous thromboembolism in cancer patients according to guidelines after educative measures.
Pillet A; Minne F; Belhadj Chaidi R; Chapelle G; Ferru A
Bull Cancer; 2018 May; 105(5):486-492. PubMed ID: 29680153
[TBL] [Abstract][Full Text] [Related]
18. [Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?].
Debourdeau P; Cossou-Gbeto C; Takam-Sohwe T; Laroche JP
Bull Cancer; 2020 Feb; 107(2):224-233. PubMed ID: 32005356
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of venous thromboembolism in elective thoracic surgery.
Gómez-Hernández MT; Rodríguez-Pérez M; Novoa-Valentín N; Jiménez-López M; Aranda-Alcaide JL; Varela-Simó G
Arch Bronconeumol; 2013 Jul; 49(7):297-302. PubMed ID: 23542046
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]